Add this topic to your myFT Digest for news straight to your inbox
FT tracker shows rapid growth in doses administered around world — but warnings come of long road ahead
US biotech says its jab also displayed ‘significant clinical efficacy’ against two virus variants
Inoculation does not require ultra-cold temperatures of BioNTech/Pfizer’s jab
Deals with J&J and Novavax bring country’s total advance orders to 340m doses
Maryland-based company plans to produce 100m doses of potential Covid-19 inoculation by January
The latest in a series on companies that have defied the gloom
International Edition